Journal
TOXICOLOGY AND APPLIED PHARMACOLOGY
Volume 254, Issue 2, Pages 65-71Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.taap.2010.03.023
Keywords
Manganese; Neurotoxicity; Dopamine synthesis; Protein kinase C; Phosphorylation; Parkinson's disease
Categories
Funding
- NIH [ES10586, NS 386344]
- W. Eugene and Linda Lloyd Endowment
Ask authors/readers for more resources
Manganese (Mn) exposure causes manganism, a neurological disorder similar to Parkinson's disease. However, the cellular mechanism by which Mn impairs the dopaminergic neurotransmitter system remains unclear. We previously demonstrated that caspase-3-dependent proteolytic activation of protein kinase C delta (PKC delta) plays a key role in Mn-induced apoptotic cell death in dopaminergic neurons. Recently, we showed that PKC delta negatively regulates tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, by enhancing protein phosphatase-2A activity in dopaminergic neurons. Here, we report that Mn exposure can affect the enzymatic activity of TH, the rate-limiting enzyme in dopamine synthesis, by activating PKC delta-PP2A signaling pathway in a dopaminergic cell model. Low dose Mn (3-10 mu M) exposure to differentiated mesencephalic dopaminergic neuronal cells for 3 h induced a significant increase in TH activity and phosphorylation of TH-Ser40. The PKC delta specific inhibitor rottlerin did not prevent Mn-induced TH activity or TH-Ser40 phosphorylation. On the contrary, chronic exposure to 0.1-1 mu M Mn for 24 h induced a dose-dependent decrease in TH activity. Interestingly, chronic Mn treatment significantly increased PKC delta kinase activity and protein phosphatase 2A (PP2A) enzyme activity. Treatment with the PKC delta inhibitor rottlerin almost completely prevented chronic Mn-induced reduction in TH activity, as well as increased PP2A activity. Neither acute nor chronic Mn exposures induced any cytotoxic cell death or altered TH protein levels. Collectively, these results demonstrate that low dose Mn exposure impairs TH activity in dopaminergic cells through activation of PKC delta and PP2A activity. (C) 2011 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available